CD274 and neoplasm: The ability of PTX to trigger ICD and upregulate PD-L1 expression after treatment suggests the potential of combined PTX and PD-1/PD-L1 blockade; from our results, significantly improved effects were observed in several tumor models with the combination of nano-PTX and PD-1 antibody.